This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Balduini, W. Articles by Cimino, M. Search for Related Content PubMed PubMed Citation Articles by Balduini, W. Articles by Cimino, M. Related Collections Animal models of human disease Behavioral Changes and Stroke Neuroprotectors

(Stroke. 2001;32:2185.)
© 2001 American Heart Association, Inc.

Original Contributions

Simvastatin Protects Against Long-Lasting Behavioral and Morphological Consequences of Neonatal Hypoxic/Ischemic Brain Injury

Walter Balduini, PhD; Valerio De Angelis, PhD; Erika Mazzoni, PhD Mauro Cimino, PhD

From the Istituto di Farmacologia e Farmacognosia, Università degli Studi di Urbino, Urbino, Italy.

Corresponding to Dr Walter Balduini, Istituto di Farmacologia e Farmacognosia, Università di Urbino, via S. Chiara 27, 61029, Urbino (PS), Italy. E-mail balduini{at}uniurb.it

Background and Purpose—— Recent studies suggest that statins (3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors) not only reduce the incidence of stroke by lowering cholesterol levels but may also exert neuroprotective effects via a mechanism not related to their lipid-lowering effect. Despite the growing body of evidence, however, the neuroprotective effect of statins in stroke is still controversial. Herein, we studied whether a prophylactic administration of simvastatin (Sim) provides significant protection against brain damage, and we sought to determine its long-lasting behavioral consequences in a neonatal model of hypoxia/ischemia.

Methods—— Newborn male rats were injected daily from postnatal days 1 to 7 with activated Sim (20 mg/kg) or an equivalent volume of vehicle. On postnatal day 7, the rats were subjected to ligation of the right common carotid artery, followed by 3 hours of hypoxia or by sham operation. The neuroprotective effect of Sim was evaluated after the rats had achieved adulthood by using a battery of behavioral tests and histological analysis.

Results—— Sim-treated ischemic rats performed the circular water maze, the radial arm maze, and the multiple-choice water maze significantly better than did vehicle-treated ischemic rats. Furthermore, in contrast to the ischemic rats, hypoxia/ischemia-injured rats pretreated with Sim were not hyperactive at weaning and showed less behavioral asymmetry. Consistently, it was found that brain damage was significantly attenuated.

Conclusions—— These findings indicate that prophylactic administration of statins may provide a potential neuroprotective strategy leading to an improvement in functional outcome in ischemic stroke. However, toxicity concern must be addressed before these agents can be directed to the asphyxiated fetus or newborn.

Key Words: cerebral ischemia • HMG-CoA reductase inhibitors • neuroprotection • newborn • rats

This article has been cited by other articles:

				J. I. Noor, T. Ikeda, K. Mishima, N. Aoo, S. Ohta, N. Egashira, K. Iwasaki, M. Fujiwara, and T. Ikenoue Short-Term Administration of a New Free Radical Scavenger, Edaravone, Is More Effective Than its Long-Term Administration for the Treatment of Neonatal Hypoxic-Ischemic Encephalopathy Stroke, November 1, 2005; 36(11): 2468 - 2474. [Abstract] [Full Text] [PDF]

				W. Balduini, E. Mazzoni, S. Carloni, M. G. De Simoni, C. Perego, L. Sironi, and M. Cimino Prophylactic but Not Delayed Administration of Simvastatin Protects Against Long-Lasting Cognitive and Morphological Consequences of Neonatal Hypoxic-Ischemic Brain Injury, Reduces Interleukin-1{beta} and Tumor Necrosis Factor-{alpha} mRNA Induction, and Does Not Affect Endothelial Nitric Oxide Synthase Expression Stroke, August 1, 2003; 34(8): 2007 - 2012. [Abstract] [Full Text] [PDF]